Pisano III Michael J DO is categorized under Internal Medicine Doctors in Philadelphia, PA and active since 1995.
Pisano III Michael J DO was established in 1995, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Pisano III at the company’s single location by writing to 1626 East Passyunk Avenue, Philadelphia, Pennsylvania PA 19148 or by phoning (215) 624-3758. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pisano III Michael J DO |
Contact Person: | Michael Pisano III |
Address: | 1626 East Passyunk Avenue, Philadelphia, Pennsylvania 19148 |
Phone Number: | (215) 624-3758 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1995 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Pisano III Michael J DO was started in 1995 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Pisano III for inquiries that concern Pisano III Michael J DO by calling the company number (215) 624-3758, as your correspondence is most welcome. Additionally, the physical location of the single location of Pisano III Michael J DO can be found at the coordinates 39.92929,-75.16425 as well as the street address 1626 East Passyunk Avenue in Philadelphia, Pennsylvania 19148.
For its online presence, you may visit Pisano III Michael J DO’s website at and engage with its social media outlets through on Twitter and on Facebook.